BMY Bristol Myers Squibb
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments namely Pharmaceuticals and Nutritionals.
$62.61 +0.70 (1.13%)
As of 04/09/2021 16:00:02 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Large cap
GICS sector: Health Care
Industry: Drug Manufacturers—General
Index country: USA
Country of incorporation: USA
IPO date: 02/09/2001
Outstanding shares: 2,233,927,936
Average volume: 11,543,377
Market cap: $139,866,228,073
Current dividend yield: 2.97%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
CUSIP: 110122108
ISIN: US1101221083
Sedol: 2126335
Valuation (See tab for details)
PE ratio: -15.51
PB ratio: 3.71
PS ratio: 3.29
Return on equity: -23.84%
Net income %: -21.20%